Floatz logo

229 assets in Metastatic Prostate Carcinoma

Therapeutic assets addressing Metastatic Prostate Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Tmpsma-02 Car T Cells
Metastatic Prostate Carcinoma
University of PennsylvaniaP1CC (43)
Vudalimab
Metastatic Prostate Carcinoma
Xencor, Inc.P2CC (43)
Zalifrelimab
Metastatic Prostate Carcinoma
ImmunoGenesisP1/2CC (43)
Fludarabine
Metastatic Prostate Carcinoma
Beijing BiotechP1CC (42)
[ 161 tb]tb psma i&t
Metastatic Prostate Carcinoma
Peter MacCallum Cancer Centre, AustraliaP1/2CC (41)
177lu htk03170
Metastatic Prostate Carcinoma
British Columbia Cancer AgencyP1/2CC (41)
177Lu-LNC1011
Metastatic Prostate Carcinoma
Peking Union Medical College HospitalP1/2CC (41)
177lu-nym032
Metastatic Prostate Carcinoma
Norroy Bioscience Co., LTDP1/2CC (41)
[²¹²pb]pb-advc001
Metastatic Prostate Carcinoma
AdvanCell Pty LimitedP1/2CC (41)
64cu-grip b
Metastatic Prostate Carcinoma
Rahul AggarwalP1/2CC (41)
68Ga-HTK03149
Metastatic Prostate Carcinoma
British Columbia Cancer AgencyP1/2CC (41)
Actinium-J591
Metastatic Prostate Carcinoma
Weill Medical College of Cornell UniversityP1CC (41)
Actinium Rhpsma-10.1
Metastatic Prostate Carcinoma
University College, LondonP1/2CC (41)
Belzutifan
Metastatic Prostate Carcinoma
Merck Sharp & Dohme LLCP1/2CC (41)
Ebastine
Metastatic Prostate Carcinoma
Rigshospitalet, DenmarkP1/2CC (41)
Fog-001
Metastatic Prostate Carcinoma
Parabilis Medicines, Inc.P1/2CC (41)
Gotistobart
Metastatic Prostate Carcinoma
OncoC4, Inc.P1/2CC (41)
gvv858
Metastatic Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (41)
Itraconazole
Metastatic Prostate Carcinoma
University of ChicagoP1CC (41)
Letrozole
Metastatic Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (41)
Masofaniten
Metastatic Prostate Carcinoma
Pedro Barata, MD, MScP2CC (41)
Nezastomig
Metastatic Prostate Carcinoma
Regeneron PharmaceuticalsP1/2CC (41)
Onct-534
Metastatic Prostate Carcinoma
Oncternal Therapeutics, IncP1/2CC (41)
Regn4336
Metastatic Prostate Carcinoma
Regeneron PharmaceuticalsP1/2CC (41)
Tinengotinib
Metastatic Prostate Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP1/2CC (41)
Tipiracil
Metastatic Prostate Carcinoma
Parabilis Medicines, Inc.P1/2CC (41)
Tmpsma-02
Metastatic Prostate Carcinoma
Tceleron Therapeutics, Inc.P1/2CC (41)
Toripalimab
Metastatic Prostate Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP1/2CC (41)
tqb3823 tablets
Metastatic Prostate Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1/2CC (41)
Trifluridine
Metastatic Prostate Carcinoma
Parabilis Medicines, Inc.P1/2CC (41)
Tulmimetostat
Metastatic Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (41)
Vibostolimab
Metastatic Prostate Carcinoma
Merck Sharp & Dohme LLCP1/2CC (41)
64cu-dota-tlx592
Metastatic Prostate Carcinoma
Telix Pharmaceuticals (Innovations) Pty LimitedEarly P1C (39)
arx517
Metastatic Prostate Carcinoma
Janssen Research & Development, LLCP1C (39)
Copanlisib
Metastatic Prostate Carcinoma
Brown UniversityP1/2C (39)
Psma-Ucar T
Metastatic Prostate Carcinoma
Shanghai Changzheng HospitalP1C (39)
ro7656594
Metastatic Prostate Carcinoma
Genentech, Inc.P1C (39)
za-001
Metastatic Prostate Carcinoma
Sichuan UniversityEarly P1C (39)
Zavondemstat
Metastatic Prostate Carcinoma
ORIC PharmaceuticalsP1C (39)
[111in]in-fl-020
Metastatic Prostate Carcinoma
Full-Life Technologies UK LimitedP1C (37)
212pb-ng001
Metastatic Prostate Carcinoma
ARTBIO Inc.Early P1C (37)
[225ac]ac-fl-020
Metastatic Prostate Carcinoma
Full-Life Technologies UK LimitedP1C (37)
Abbv-969
Metastatic Prostate Carcinoma
AbbVieP1C (37)
[Ac-225]-Psma-62
Metastatic Prostate Carcinoma
Eli Lilly and CompanyP1C (37)
azd2275
Metastatic Prostate Carcinoma
AstraZenecaP1C (37)
azd2284
Metastatic Prostate Carcinoma
AstraZenecaP1C (37)
bay3546828
Metastatic Prostate Carcinoma
BayerP1C (37)
Bms-986460
Metastatic Prostate Carcinoma
Bristol-Myers SquibbP1C (37)
Dntgfβrii-Armoured Steap2-Targeted Autologous Car T-Cell
Metastatic Prostate Carcinoma
Shanghai AbelZeta Ltd.P1C (37)
ds9051b
Metastatic Prostate Carcinoma
Daiichi SankyoP1C (37)
Showing 151 to 200 of 229 assets
PreviousPage 4 of 5Next